Task: Answer the multiple-choice question.
Question: Which drug exhibits a 15.842\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) N#Cc1ccccc1OCC(=O)NNC(=O)CNC(=O)c1cccc(Br)c1
(b) CCC(C)NC(=O)C1CCCN(c2nc(C)cc(OC)n2)C1
(c) Cc1cccc(NC(=O)CN2CCc3cc4c(cc3C2)OCCCO4)c1
Answer: b. CCC(C)NC(=O)C1CCCN(c2nc(C)cc(OC)n2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)C1CCCN(c2nc(C)cc(OC)n2)C1
CCC(C)NC(=O)C1CCCN(c2nc(C)cc(OC)n2)C1
N-butan-2-yl-1-(4-methoxy-6-methylpyrimidin-2-yl)piperidine-3-carboxamide